Covered recipient · General Payments record
JOHN T BRENNAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$2,535.18
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $133.08 | 8 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $29.55 | 2 |
| Merck Sharp & Dohme Corporation | $23.88 | 1 |
| Abbott Laboratories | $17.94 | 1 |
| ABBVIE INC. | $16.72 | 1 |
| Amgen Inc. | $16.20 | 1 |
| Novo Nordisk AS | $15.39 | 1 |
| PFIZER INC. | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.94 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1018476215 | CMS |
| AbbVie Inc. | $16.72 | 03/15/2023 | Food and Beverage | Undisputed | 01/23/2026 | 996303463 | CMS |
| Amgen Inc. | $16.20 | 01/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020605213 | CMS |
| GlaxoSmithKline, LLC. | $14.24 | 01/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001005459 | CMS |
| GlaxoSmithKline, LLC. | $15.31 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001012893 | CMS |
| Merck Sharp & Dohme LLC | $23.88 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1048405349 | CMS |
| Novo Nordisk Inc | $15.39 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000422383 | CMS |
| PFIZER INC. | $13.40 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050576457 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.